RxDoctor Payments Data

Sebastian Ksionski, MD

Pain Medicine · Lynchburg, VANPI 1033120852

Payments from drug & device makers

$2,334in general payments, 2019–2025

Across 31 payments — averaging $75.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Derma Sciences, Inc.$1K
  • Boston Scientific$721
  • Medtronic$137
  • Abbott$75
  • GRT US Holding, Inc.$45
  • SPR Therapeutics, Inc$36
  • plus $49 from 3 others
$1,122in research payments, 2019–2025

Across 1 payment — averaging $1122.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Integra Lifesciences Corporation$1K

What the payments were for

  • Travel & lodging$1,12248%
  • Food & beverage$1,21252%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Derma Sciences, Inc.7$1,270
Boston Scientific15$721
Medtronic1$137
Abbott3$75
GRT US Holding, Inc.1$45
SPR Therapeutics, Inc1$36
Stryker1$25
Baudax Bio Inc.1$19
Orthofix Medical, Inc.1$5

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,334 in reported general payments places this provider in the 55th percentile of 150 pain medicine providers in Virginia.

See all pain medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$122,493
Medicare patients
246
Services billed
2,049

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl67$23,427
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,120$19,492
BelbucaBuprenorphine Hcl34$17,013
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen810$16,246
Xtampza ErOxycodone Myristate30$16,220
Fentanyl139$15,774
NucyntaTapentadol Hcl16$11,985
Pregabalin315$9,666
Gabapentin717$9,124
Morphine Sulfate ErMorphine Sulfate204$6,429
ButransBuprenorphine11$5,646
Oxycodone Hcl428$5,515
Tramadol Hcl ErTramadol Hcl44$3,119
Buprenorphine13$2,441
Diclofenac Sodium175$2,269

Paid to pharmacies, not to this prescriber.

Other pain medicine in Lynchburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →